Latest News and Press Releases
Want to stay updated on the latest news?
-
Albany, NY: , Nov. 06, 2018 (GLOBE NEWSWIRE) -- Transparency Market Research (TMR) has published a new report titled, “Drug Eluting Balloon Market - Global Industry Analysis, Size, Share, Growth,...
-
BALA CYNWYD, Pa., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ: HLNE) today reported results for its second fiscal quarter ended...
-
GAITHERSBURG, Md., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will participate in the following...
-
Proceeds Expected to be Sufficient to Fund Company’s Liberatus Phase 3 Clinical Trial for RP-G28 for Lactose Intolerance Through Announcement of Top-Line Data Anticipated in the Second Half of 2019...
-
ROUYN-NORANDA, Quebec, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Radisson Mining Resources Inc. (“Radisson” or the “Company") is pleased to announce the appointment of Mr. Sylvain Doire as Environment and...
-
Revenue increased 56%, Gross Profit rose 113% Gross Profit Margin was 15.8%, EBITDA improved 157% from prior year Conference call to be held today at 9:00 A.M. EST HOUSTON, Nov. 06, 2018 (GLOBE...
-
SAN DIEGO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) today announced it will release third quarter 2018 financial results after the close of trading on Tuesday,...
-
APeX-2 study enrollment completed, results on-track for Q2 2019 RESEARCH TRIANGLE PARK, N.C., Nov. 06, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced...
-
Record Quarterly Operating Income Increases to $28.3 million Third Quarter 2018 Highlights Operating revenue of $158.7 millionOperating income of $28.3 millionNet income of $15.5 million, resulting...
-
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Nov. 06, 2018 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...